3.96 USD
▲-0.11+4.21%
盘后 3.85 +1.32%
2026-08-03
市值
$1.26B
市盈率
—
EPS
-0.09
股息率
—
52 周区间
2.23 – 6.51
成交量
5.12M
Beta
1.09
目标价
7.72
52W 低 2.2352W 高 6.51
价格走势
公司简介
MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. It develops and commercializes treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease. It offers Afrezza inhalation powder, an inhaled insulin used to improve glycemic control in adults with diabetes; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in...